Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-2847
Full Text
Open PDFAbstract
Available in full text
Date
January 15, 2019
Authors
Publisher
American Association for Cancer Research (AACR)